See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Klonopin, Rivotril, PMS-Clonazepam
What is Clonazepam? Clonazepam, a benzodiazepine, is used alone or as an adjunct in the treatment of seizure disorders and for panic disorders. Off label it is used for restless leg syndrome, neuralgia, multifocal tic disorder, parkinsonian dysarthria, bipolar disorder and as an adjunct in treatment of schizophrenia.
See more information, including instructions, precautions, side effects, and interactions.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Anxiety | 45 | 24% |
| Insomnia | 42 | 22% |
| Other | 21 | 11% |
| Treat Parkinson's | 10 | 5% |
| Disordered muscle tension (dystonia) | 10 | 5% |
| Muscle cramping, spasms | 7 | 3% |
| Dystonia | 4 | 2% |
| Sleep problems | 3 | 1% |
| REM Sleep Behavior Disorder | 2 | 1% |
| Restless Legs Syndrome (RLS) | 2 | 1% |
| 0.125 mg all the time (24/7) | 0.125mg as needed | 0.25mg as needed | 0.5 mg as needed | 0.5mg as needed | 1mg as needed | 2 0.5mg as needed | 2mg as needed | as needed | daily | mg as needed | 0.125 mg daily | 0.25 mg daily | 0.5 mg daily | 0.375 mg daily | 0.5 mg daily | 0.75 mg daily | 1 mg daily | 1.5 mg daily | 2 mg daily | 2.5 mg daily | 3 mg daily | 4 mg daily | 6 mg daily | 10 mg daily | 12 other daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
1
|
13
|
3
|
1
|
1
|
1
|
1
|
1
|
7
|
3
|
1
|
1
|
51
|
1
|
38
|
9
|
10
|
1
|
7
|
2
|
2
|
1
|
1
|
||
How long current patients have been taking Clonazepam or how long patients were taking Clonazepam before stopping.
Results from 30 patient evaluations. See the overall results and all individual evaluations.
| Moderate | 71% | 5 |
|---|---|---|
| Slight | 29% | 2 |
Treat Parkinson's
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 17% | 5 |
| Mild | 37% | 11 |
| None | 47% | 14 |
Top reported side-effects include: Drowsiness, Sleepiness, Groggy in morning
Summary results are based on 30 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Report created on November 08, 2009.